Literature DB >> 20345366

Osteoblastoma of the sternum--case report and review of the literature.

Camilo E Villalobos1, Leon D Rybak, German C Steiner, James C Wittig.   

Abstract

Osteoblastoma is an extremely rare entity that represents less than 1% of all bone tumors, and affects twice as many males as females with peak incidence between 15 and 20 years. Osteoblastomas commonly affect axial bones, long bones, bones of the foot and hand, and less commonly the pelvis, scapula, ribs, and clavicle. Osteoblastoma does not have a classic presentation, but can vary with the location and size of the tumor. The main complaint is often progressive pain localized at the tumor site. Osteoblastoma is a benign tumor with an aggressive behavior. The treatment is wide surgical resection, otherwise it continues to enlarge and destroy the bone and surrounding structures. We report a 32-year-old male with an osteoblastoma of this sternum who was treated with an en-bloc resection and reconstruction with Marlex((R)) and a methylmethacrylate plate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345366

Source DB:  PubMed          Journal:  Bull NYU Hosp Jt Dis        ISSN: 1936-9719


  4 in total

1.  Femur mass in a 43-year-old woman.

Authors:  Yan Epelboym; Kapil R Desai; Roberto Garcia; James C Wittig
Journal:  Clin Orthop Relat Res       Date:  2012-05-12       Impact factor: 4.176

Review 2.  Osteoblastoma of the clavicle at the site of a previous fracture-first case report and review of the literature.

Authors:  Adriana C Moreira; David I Suster; Sterling Ellis Eide; Daniel I Rosenthal; Connie Y Chang
Journal:  Skeletal Radiol       Date:  2019-03-08       Impact factor: 2.199

3.  Surgical treatment of tumours of the sternum - 10 years' experience.

Authors:  Katarzyna Kozak; Mariusz P Łochowski; Adam Białas; Michał Rusinek; Józef Kozak
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-09-30

4.  Cytological diagnosis of osteoblastoma of the talus: Case report with unusual presentation and diagnostic pitfalls.

Authors:  Smita Chandra; Neeti Puri; Meena Harsh; Anil Kumar Juyal
Journal:  Cytojournal       Date:  2018-08-27       Impact factor: 2.091

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.